APO RESEARCH · REPORT
Biomarkers
In biological system, it means to calculate the whole number by marking part of individuals.
Product & engineering
Understand the product.
In biological system, it means to calculate the whole number by marking part of individuals.
Selected research
Industry Research
Biomarkers Industry Research Report 2026
Market perspective
In biological system, it means to calculate the whole number by marking part of individuals.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
Report Scope
Read the full market overview
This report quantifies the global Biomarkers market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomarkers.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomarkers Market by Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
Agilent Technologies
Biomarkers Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other
Biomarkers Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other
Biomarkers Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarkers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sepsis Biomarkers
- Antibiotic Resistance Biomarkers
- Traumatic Brain Injury (TBI) Testing Biomarkers
- Stroke Testing Biomarkers
- Antibiotic Stewardship Biomarkers
- Other
Applications
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Other
Companies covered
- Thermo Fisher Scientific
- Merck
- Bio-Rad Laboratories
- QIAGEN
- Roche
- Danaher Corporation
- Siemens Healthcare
- Abbott
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomarkers by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Sepsis Biomarkers
- 2.2.3 Antibiotic Resistance Biomarkers
- 2.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
- 2.2.5 Stroke Testing Biomarkers
- 2.2.6 Antibiotic Stewardship Biomarkers
- 2.2.7 Other
- 2.3 Biomarkers by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnostics
- 2.3.3 Drug Discovery
- 2.3.4 Personalized Medicine
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Biomarkers Breakdown Data by Type
- 3.1 Global Biomarkers Historic Market Size by Type (2021-2026)
- 3.2 Global Biomarkers Forecasted Market Size by Type (2027-2032)
4 Biomarkers Breakdown Data by Application
- 4.1 Global Biomarkers Historic Market Size by Application (2021-2026)
- 4.2 Global Biomarkers Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomarkers Market Perspective (2021-2032)
- 5.2 Global Biomarkers Growth Trends by Region
- 5.2.1 Global Biomarkers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomarkers Historic Market Size by Region (2021-2026)
- 5.2.3 Biomarkers Forecasted Market Size by Region (2027-2032)
- 5.3 Biomarkers Market Dynamics
- 5.3.1 Biomarkers Industry Trends
- 5.3.2 Biomarkers Market Drivers
- 5.3.3 Biomarkers Market Challenges
- 5.3.4 Biomarkers Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomarkers Players by Revenue
- 6.1.1 Global Top Biomarkers Players by Revenue (2021-2026)
- 6.1.2 Global Biomarkers Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomarkers Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomarkers Head Office and Area Served
- 6.4 Global Biomarkers Players, Product Type & Application
- 6.5 Global Biomarkers Manufacturers Established Date
- 6.6 Global Biomarkers Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomarkers Market Size (2021-2032)
- 7.2 North America Biomarkers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomarkers Market Size by Country (2021-2026)
- 7.4 North America Biomarkers Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomarkers Market Size (2021-2032)
- 8.2 Europe Biomarkers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomarkers Market Size by Country (2021-2026)
- 8.4 Europe Biomarkers Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomarkers Market Size (2021-2032)
- 9.2 Asia-Pacific Biomarkers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomarkers Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomarkers Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomarkers Market Size (2021-2032)
- 10.2 South America Biomarkers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomarkers Market Size by Country (2021-2026)
- 10.4 South America Biomarkers Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomarkers Market Size (2021-2032)
- 11.2 Middle East & Africa Biomarkers Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomarkers Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomarkers Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Biomarkers Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Biomarkers Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Merck
- 12.2.1 Merck Company Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Revenue in Biomarkers Business (2021-2026)
- 12.2.4 Merck Biomarkers Product Portfolio
- 12.2.5 Merck Recent Developments
- 12.3 Bio-Rad Laboratories
- 12.3.1 Bio-Rad Laboratories Company Information
- 12.3.2 Bio-Rad Laboratories Business Overview
- 12.3.3 Bio-Rad Laboratories Revenue in Biomarkers Business (2021-2026)
- 12.3.4 Bio-Rad Laboratories Biomarkers Product Portfolio
- 12.3.5 Bio-Rad Laboratories Recent Developments
- 12.4 QIAGEN
- 12.4.1 QIAGEN Company Information
- 12.4.2 QIAGEN Business Overview
- 12.4.3 QIAGEN Revenue in Biomarkers Business (2021-2026)
- 12.4.4 QIAGEN Biomarkers Product Portfolio
- 12.4.5 QIAGEN Recent Developments
- 12.5 Roche
- 12.5.1 Roche Company Information
- 12.5.2 Roche Business Overview
- 12.5.3 Roche Revenue in Biomarkers Business (2021-2026)
- 12.5.4 Roche Biomarkers Product Portfolio
- 12.5.5 Roche Recent Developments
- 12.6 Danaher Corporation
- 12.6.1 Danaher Corporation Company Information
- 12.6.2 Danaher Corporation Business Overview
- 12.6.3 Danaher Corporation Revenue in Biomarkers Business (2021-2026)
- 12.6.4 Danaher Corporation Biomarkers Product Portfolio
- 12.6.5 Danaher Corporation Recent Developments
- 12.7 Siemens Healthcare
- 12.7.1 Siemens Healthcare Company Information
- 12.7.2 Siemens Healthcare Business Overview
- 12.7.3 Siemens Healthcare Revenue in Biomarkers Business (2021-2026)
- 12.7.4 Siemens Healthcare Biomarkers Product Portfolio
- 12.7.5 Siemens Healthcare Recent Developments
- 12.8 Abbott
- 12.8.1 Abbott Company Information
- 12.8.2 Abbott Business Overview
- 12.8.3 Abbott Revenue in Biomarkers Business (2021-2026)
- 12.8.4 Abbott Biomarkers Product Portfolio
- 12.8.5 Abbott Recent Developments
- 12.9 Agilent Technologies
- 12.9.1 Agilent Technologies Company Information
- 12.9.2 Agilent Technologies Business Overview
- 12.9.3 Agilent Technologies Revenue in Biomarkers Business (2021-2026)
- 12.9.4 Agilent Technologies Biomarkers Product Portfolio
- 12.9.5 Agilent Technologies Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst